文献速递乳腺MR

三阴性乳腺癌患者乳腺动态增强MRI灌注参数与疾病特异性生存相关

Perfusion Parameters on Breast Dynamic Contrast-Enhanced MRI Are Associated With Disease-Specific Survival in Patients With Triple-Negative Breast Cancer.
PubMed 文献 · AJR Am J Roentgenol · 2016-12-22

纳入61例三阴性乳腺癌患者,分析治疗前MRI灌注参数与无病生存(DFS)和疾病特异性生存(DSS)的关系。中位随访46.1个月,多因素分析显示治疗前较高的ve值(HR=1.658,p=0.038)、较高峰值强化(HR=1.843,p=0.018)及较大肿瘤尺寸(HR=1.060,p=0.001)与更差DSS独立相关。

要点

  • 治疗前MRI较高ve值、较高峰值强化及较大肿瘤尺寸是三阴性乳腺癌DSS较差的独立预测因子。
  • 治疗前MRI肿瘤尺寸较大与DFS较差相关(单因素HR=1.024,p=0.003)。
  • 术后病理肿瘤较大及腋窝淋巴结转移与DFS和DSS较差相关。

核心结论

  • 治疗前MRI原发肿瘤较高的ve值、较高峰值强化及较大肿瘤尺寸是三阴性乳腺癌患者DSS较差的独立预测因子。

研究设计与样本

  • 回顾性分析61例三阴性乳腺癌患者(中位年龄50岁,范围27-77岁;MRI肿瘤中位尺寸25.5 mm,范围11.0-142.0 mm),分析临床、病理及MRI参数,采用Cox比例风险模型确定与生存结局的关联。

诊断标准与关键数值

  • 治疗前多因素模型预测DSS:ve值较高HR=1.658(p=0.038),峰值强化较高HR=1.843(p=0.018),MRI肿瘤尺寸较大HR=1.060(p=0.001)。
  • 治疗前单因素分析预测DFS:MRI肿瘤尺寸较大HR=1.024(p=0.003)。
  • 治疗后多因素模型预测DFS:病理肿瘤尺寸较大HR=1.074(p=0.005),腋窝淋巴结转移HR=5.789(p=0.017)。
  • 治疗后多因素模型预测DSS:病理肿瘤尺寸较大HR=1.050(p=0.042),腋窝淋巴结转移HR=23.717(p=0.005)。

临床应用与阅片要点

  • 治疗前乳腺动态增强MRI报告的灌注参数(ve值、峰值强化)及肿瘤尺寸可能为三阴性乳腺癌DSS预后评估提供信息。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The aim of this study was to investigate the association between perfusion parameters on MRI performed before treatment and survival outcome (disease-free survival [DFS], disease-specific survival [DSS]) in patients with triple-negative breast cancer (TNBC).

MATERIALS AND METHODS: Sixty-one patients (median age, 50 years; age range, 27-77 years) with TNBC (tumor size on MRI: median, 25.5 mm; range, 11.0-142.0 mm) were included. We analyzed clinical and pathologic variables and MRI parameters. Cox proportional hazards models were used to determine associations with survival outcome.

RESULTS: The median follow-up time was 46.1 months (range, 13.9-58.4 months). Eleven of 61 (18.0%) patients had events (i.e., local, regional, or distant recurrence or contralateral breast cancer) and seven (11.5%) died of breast cancer. Among the pretreatment variables, a larger tumor size on MR images (hazard ratio [HR] = 1.024, p = 0.003) was associated with worse DFS at univariate analysis. In multivariate pretreatment models for DSS, a higher fractional volume of extravascular extracellular space per unit volume of tissue (ve) value (HR = 1.658, p = 0.038), higher peak enhancement (HR = 1.843, p = 0.018), and a larger tumor size on MR images (HR = 1.060, p = 0.001) were associated with worse DSS. In multivariate posttreatment models, a larger pathologic tumor size (HR for DFS, 1.074 [p = 0.005]; HR for DSS, 1.050 [p = 0.042]) and metastasis in surgically resected axillary lymph nodes (HR for DFS, 5.789 [p = 0.017]; HR for DSS, 23.717 [p = 0.005]) were associated with worse survival outcome.

CONCLUSION: A higher ve value, higher peak enhancement, and larger tumor size of the primary tumor on pretreatment MRI were independent predictors of worse DSS in patients with TNBC.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Park VY, Kim EK, Kim MJ, et al. Perfusion Parameters on Breast Dynamic Contrast-Enhanced MRI Are Associated With Disease-Specific Survival in Patients With Triple-Negative Breast Cancer. AJR Am J Roentgenol. 2016. PMID: 28004976. doi:10.2214/AJR.16.16476

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。